Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
Authors: Katz MHG; The University of Texas MD Anderson Cancer Center, Houston., Shi Q; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Meyers J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Herman JM; Northwell Cancer Institute, National Cancer Institute Community Oncology Research Program, Manhasset, New York., Chuong M; Miami Cancer Institute, Miami, Florida., Wolpin BM; Dana-Farber/Partners CancerCare, Boston, Massachusetts., Ahmad S; University of Cincinnati, Cincinnati, Ohio., Marsh R; NorthShore University Health System, Evanston, Illinois., Schwartz L; Columbia University, New York, New York., Behr S; University of California, San Francisco., Frankel WL; The Ohio State University Arthur G James Cancer Hospital, Columbus., Collisson E; University of California, San Francisco., Leenstra J; St. Mary's Hospital, Oneida, Wisconsin., Williams TM; City of Hope National Medical Center, Duarte, California., Vaccaro G; Oregon Health and Science University, Portland., Venook A; University of California, San Francisco., Meyerhardt JA; Dana-Farber/Partners CancerCare, Boston, Massachusetts., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.
Source: JAMA oncology [JAMA Oncol] 2022 Sep 01; Vol. 8 (9), pp. 1263-1270.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2022.2319